Pilot trial assessing the feasibility of intra-ductal delivery of epirubicin (epi)-containing nanoparticles (NP) via InDuct@ Breast Microcatheter (IDBM)

MLA

Robert J. Goulet, et al. “Pilot Trial Assessing the Feasibility of Intra-Ductal Delivery of Epirubicin (Epi)-Containing Nanoparticles (NP) via InDuct@ Breast Microcatheter (IDBM).” Journal of Clinical Oncology, vol. 22, July 2004, p. 828. EBSCOhost, https://doi.org/10.1200/jco.2004.22.90140.828.

APA

Robert J. Goulet, Amv Storniolo, Sunil Badve, C. Huntley, D. Rouch, & L. Brannon-Peppas. (2004). Pilot trial assessing the feasibility of intra-ductal delivery of epirubicin (epi)-containing nanoparticles (NP) via InDuct@ Breast Microcatheter (IDBM). Journal of Clinical Oncology, 22, 828. https://doi.org/10.1200/jco.2004.22.90140.828

Chicago

Robert J. Goulet, Amv Storniolo, Sunil Badve, C. Huntley, D. Rouch, and L. Brannon-Peppas. 2004. “Pilot Trial Assessing the Feasibility of Intra-Ductal Delivery of Epirubicin (Epi)-Containing Nanoparticles (NP) via InDuct@ Breast Microcatheter (IDBM).” Journal of Clinical Oncology 22 (July): 828. doi:10.1200/jco.2004.22.90140.828.